Blurred symmetry in Q1 fund performance figures
5 Apr 16
What a difference a year makes. In the first quarter of 2015, the top 10 funds were a mixture of Japanese equities, Russian equities, and biotechnology funds, with a frontier markets fund rounding things out.
Healthcare
Expanding on the biotech theme however, healthcare funds also had a tough time of things over the first quarter. The $202m JB Multistock Health Innovation Fund lost 13.6% over the three months, while the Invesco Global Health Care Fund took up seventh position with a fall of 12%.
